TEMPUS LABS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • October 19th, 2022 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • Delaware
Contract Type FiledOctober 19th, 2022 Company Industry JurisdictionThis INDEMNIFICATION AGREEMENT (this “Agreement”) is dated as of _________________, 20__ and is between Tempus Labs, Inc., a Delaware corporation (the “Company”), and ______________ (“Indemnitee”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 19th, 2022 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • Delaware
Contract Type FiledOctober 19th, 2022 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT dated as of January 1, 2022 (“Agreement”) is by and between JIM ROGERS (“Executive”) and TEMPUS LABS, INC. (“Company”).
CREDIT AGREEMENT dated as of September 22, 2022 among TEMPUS LABS, INC., as the Borrower The Lenders Party Hereto from Time to Time, and ARES CAPITAL CORPORATION, as Administrative Agent and Collateral Agent ARES CAPITAL MANAGEMENT LLC, as Lead...Credit Agreement • October 19th, 2022 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • New York
Contract Type FiledOctober 19th, 2022 Company Industry JurisdictionThis CREDIT AGREEMENT is entered into as of September 22, 2022, by and among TEMPUS LABS, INC., a Delaware corporation (the “Borrower”), the Lenders party hereto from time to time, ARES CAPITAL CORPORATION, as Administrative Agent, and ARES CAPITAL MANAGEMENT LLC, as Lead Arranger and Bookrunner.
TENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • October 19th, 2022 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • Delaware
Contract Type FiledOctober 19th, 2022 Company Industry JurisdictionThis TENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of April 18, 2022, by and among Tempus Labs, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of whom is referred to in this Agreement as an “Investor” and each of the stockholders listed on Schedule B hereto, each of whom is referred to in this Agreement as a “Common Holder.”
STRATEGIC COLLABORATION AGREEMENT between GLAXOSMITHKLINE LLC and TEMPUS LABS, INC.Strategic Collaboration Agreement • October 19th, 2022 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • Delaware
Contract Type FiledOctober 19th, 2022 Company Industry JurisdictionTHIS STRATEGIC COLLABORATION AGREEMENT (the “Agreement”) is dated as of August 1, 2022 (the “Effective Date”) and made between GLAXOSMITHKLINE LLC, a limited liability company with its principal place of business located at 5 Crescent Drive, Philadelphia, PA 19112, United States (“GSK”); and TEMPUS LABS, INC., a corporation with its principal place of business located at 600 West Chicago Avenue, Chicago, Illinois 60654 (“Tempus”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 19th, 2022 • Tempus Labs, Inc. • Services-computer programming, data processing, etc. • Delaware
Contract Type FiledOctober 19th, 2022 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT dated as of January 1, 2022 (“Agreement”) is by and between ERIC LEFKOFSKY (“Executive”) and TEMPUS LABS, INC. (“Company”).